Posted in

Pau d’Arco (Tabebuia impetiginosa)

Nomenclature & Taxonomic Classification

  • Botanical Binomial: Tabebuia impetiginosa (Mart. ex DC.) Standl. (Synonym: Handroanthus impetiginosus)
  • Family: Bignoniaceae
  • Common Name(s): Pau d’Arco, Lapacho, Taheebo, Purple Guayacan
  • Parts Used: Inner bark (phloem).

Botanical Description, Habitat & Sustainability

  • Physical Description: * Growth Habit: Large canopy tree growing up to 30 meters high.
    • Morphology: Opposite, digitate leaves and large, showy pink to purple trumpet-shaped flowers. The inner bark is dense, fibrous, and yellowish-tan when freshly cut.
  • Habitat & Cultivation: Native to the tropical rainforests of Central and South America, particularly Brazil, Argentina, and Paraguay.
  • Sustainability Status: Vulnerable in the wild due to overharvesting for lumber and medicinal bark. Wildcrafting must be monitored; ethically wild-harvested or sustainably managed sources are critical.

Energetics & Traditional Actions

  • Western Tissue States: Corrects Irritation (heat/inflammation) and Torpor/Putrefaction (tissue stagnation/infection).
  • Traditional Vector:
    • Ayurveda: Rasa (Taste): Tikta (Bitter), Kashaya (Astringent) | Virya (Energy): Shita (Cooling) | Vipaka (Post-Digestive Effect): Katu | Dosha Modulation: Reduces Pitta and Kapha.
    • Traditional Chinese Medicine: Temperature: Cold | Taste: Bitter | Organ Meridians Entered: Spleen, Large Intestine, Liver.
  • Historical Folk Use: Extensively used by the Callawaya, Tupi, and Guarani tribes for centuries to treat deep-seated infections, malaria, fevers, and systemic malignancies.

Phytochemistry & Pharmacological Dynamics

  • Primary Phytochemicals: Naphthoquinones (lapachol, beta-lapachone), anthraquinones, flavonoids, and coumarins.
  • Mechanism of Action: > Lapachol and beta-lapachone interfere with electron transport systems within the mitochondrial membrane of fungi and bacteria, inducing oxidative stress and inhibiting DNA/RNA synthesis. They also induce apoptosis in compromised cell lines via the inhibition of Topoisomerase I and II.

Clinical Applications & Indications

  • Primary Indications: Chronic candidiasis (intestinal and vaginal), fungal dermatophytosis, systemic dysbiosis, and chronic bacterial infections.
  • Secondary Indications: Supporting therapy for inflammatory bowel diseases, rheumatoid arthritis, and adjunctive immune support.
  • Modern Clinical Evidence: Extensive in-vitro and animal testing validates its significant antifungal, antibacterial, and antineoplastic capabilities, though isolated lapachol can cause toxicity that the whole-plant extract bypasses.

Preparation, Dosing & Extraction Matrix

  • Optimal Menstruum & Extraction Guidelines: Must be decocted for a long duration to extract the dense naphthoquinones; cold water or short infusions are entirely ineffective. Tinctures require a high-alcohol menstruum (60–70% EtOH) to dissolve lapachol.

Standard Dosage Parameters

Delivery MethodStandard Clinical DosageFrequency / Administration
Crude Herb Powder2–5 gramsDaily in capsules
Decoction1–2 tablespoons of bark per pintSimmered covered for 20–30 mins, 3x daily
Tincture (1:5)2–4 mLThree times daily in water
Fluid Extract (1:1)1–2 mLTwice daily

Safety Profile, Contraindications & Drug Interactions

  • Contraindications: Contraindicated during pregnancy due to potential teratogenic effects of isolated naphthoquinones. Contraindicated for individuals on concurrent anticoagulant therapy.
  • Side Effects & Toxicity Thresholds: High doses of isolated lapachol cause nausea, vomiting, and prolonged prothrombin time. Whole bark is generally safe within standard limits.
  • Pharmaceutical Cross-Interactions: * Enzyme Alterations: Minor CYP profiling interactions.
    • Additive Pathways: Potentiates antiplatelet and anticoagulant medications (e.g., Warfarin, Aspirin) increasing risk of bleeding.

References

  1. Schwontkowski, D. Herbs of the Amazon: Traditional Medicine and Pharmacology.
  2. Mills, S., & Bone, K. Principles and Practice of Phytotherapy.
  3. Castellanos, J. R., et al. (2009). “Immune effects of Tabebuia impetiginosa.” Journal of Ethnopharmacology.